4
Changes in Ownership
HAEMONETICS CORP Filed Acc 0000313143-13-000166
President & CEO sold 3,000 shares at $39.88 ($119,647)
- President & CEO acquired 3,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
CONCANNON BRIAN · President & CEO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2013-10-01 | Exercise or conversion : show line 1 in the form | +3,000 | $13.05 | $39,158 | 118,798 | D |
| 2013-10-01 | Sale : show line 2 in the form | −3,000 | $39.88 | $119,647 | 115,798 | D |
| Open-market sales · 3,000 sh · avg $39.88 · $119,647 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|
| 2013-10-01 | Exercise or conversion : show line 3 in the form Non-Qualified Stock Option (right to buy) | −3,000 | $39.88 | $119,647 | $13.05 | 2014-05-05 | 3,000 | 12,000 | D |
Loading xslF345X03/edgardoc.xml…